Hemogenyx Pharmaceuticals (LSE:HEMO) Days Payable: (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:HEMO Hemogenyx Pharmaceuticals PLC LSE:HEMO
20 GF Score
Price £4.39
! 2 Warning Signs
View Full Analysis

What is Hemogenyx Pharmaceuticals Days Payable?

Hemogenyx Pharmaceuticals's average Accounts Payable for the six months ended in Dec. 2025 was £0.00 Mil. Hemogenyx Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2025 was £0.27 Mil. Hence, Hemogenyx Pharmaceuticals's Days Payable for the six months ended in Dec. 2025 was 0.00.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's Days Payable or its related term are showing as below:

LSE:HEMO' s Days Payable Range Over the Past 10 Years
Min: 51.39   Med: 82.76   Max: 323.4
Current: 323.4

During the past 10 years, Hemogenyx Pharmaceuticals's highest Days Payable was 323.40. The lowest was 51.39. And the median was 82.76.

LSE:HEMO's Days Payable is ranked better than
72.95% of 706 companies
in the Biotechnology industry
Industry Median: 111.165 vs LSE:HEMO: 323.40

Hemogenyx Pharmaceuticals's Days Payable stayed the same from Dec. 2024 () to Dec. 2025 ().

Hemogenyx Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Hemogenyx Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemogenyx Pharmaceuticals Days Payable Chart

Hemogenyx Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 854.66 191.43 - - -

Hemogenyx Pharmaceuticals Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LSE:HEMO vs VRTX, REGN, MRNA: Days Payable Comparison

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's Days Payable falls into.


LSE:HEMO
20GF Score
Hemogenyx Pharmaceuticals PLC LSE:HEMO
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemogenyx Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hemogenyx Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0.588753*365
=0 / 0.588753*365
=0.00

Hemogenyx Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0.27497*365 / 2
=0 / 0.27497*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemogenyx Pharmaceuticals Business Description

Address 6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments. The Group has one reportable segment, the discovery, development, and commercialisation of treatments relating to blood and immune system disorders and viral infections, and administrative functions in the United Kingdom. It has its presence in United Kingdom; and United States.
20GF Score

Get the complete analysis for LSE:HEMO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£4.39
Price